Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IDEX Biometrics ASAIDXAF 26 Debt-to-Equity is 0.00 as of Mar. 2026. GuruFocus rates IDXAF with a GF Score™ of 26/100 and a GF Value™ of $0.01 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 2,248 Software companies, IDEX Biometrics ASA ranks worse than 44483.94% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for IDEX Biometrics ASA's Debt-to-Equity or its related term are showing as below:
IDXAF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.09 Max: 14.77
Current: -3.26
During the past 13 years, the highest Debt-to-Equity Ratio of IDEX Biometrics ASA was 14.77. The lowest was 0.01. And the median was 0.09.
IDXAF's Debt-to-Equity is not ranked
in the Software industry.
Industry Median: 0.19
vs IDXAF: -3.26
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
IDEX Biometrics ASA Debt-to-Equity Related Terms
IDEX Biometrics ASA Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for IDEX Biometrics ASA's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDXAF vs QH, SHOP, UBER: Debt-to-Equity Comparison
For the Software - Application subindustry, IDEX Biometrics ASA's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEX Biometrics ASA Debt-to-Equity vs Software Industry
For the Software industry and Technology sector, IDEX Biometrics ASA's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where IDEX Biometrics ASA's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEX Biometrics ASA (IDXAF) has a Debt-to-Equity of 0.00 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on IDEX Biometrics ASA and its competitors. Over the past decade, IDEX Biometrics ASA's Debt-to-Equity has ranged from 0.01 to 14.77. According to the industry distribution chart, IDEX Biometrics ASA ranks #999999 out of 2248 companies in the Software industry.
Is IDEX Biometrics ASA's Debt-to-Equity too high?
IDEX Biometrics ASA's current Debt-to-Equity is 0.00. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 14.77. Based on the distribution chart, IDEX Biometrics ASA ranks #999999 out of 2248 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, IDEX Biometrics ASA has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IDEX Biometrics ASA's Debt-to-Equity compare to QH and SHOP?
According to the Software industry distribution chart, IDEX Biometrics ASA ranks #999999 out of 2248 companies for Debt-to-Equity. This places IDEX Biometrics ASA in the lower half of its industry. The industry median Debt-to-Equity is 0.19. Historically, IDEX Biometrics ASA's own Debt-to-Equity has ranged from 0.01 to 14.77 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Software company?
The median Debt-to-Equity among Software companies is 0.19, based on 2,248 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on IDEX Biometrics ASA and its competitors. For the Software industry, the median Debt-to-Equity is 0.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDEX Biometrics ASA's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEX Biometrics ASA stock overvalued right now?
Based on GuruFocus' analysis, IDEX Biometrics ASA (IDXAF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.89 — trading 8800% above its estimated fair value. The current Debt-to-Equity is 0.00. IDEX Biometrics ASA's overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For IDEX Biometrics ASA (IDXAF), the current Debt-to-Equity is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IDEX Biometrics ASA (IDXAF) Overvalued in 2026?
Based on GuruFocus' analysis, IDEX Biometrics ASA stock appears to be overvalued.
The current stock price of $0.89 is trading 8800% above its estimated GF Value™ of $0.01.
GuruFocus considers IDEX Biometrics ASA to be Significantly Overvalued.
Key valuation signals for IDXAF:
Debt-to-Equity: 0.00
GF Value™: $0.01 vs. price of $0.89 (8800% above fair value)
No single metric tells the full story. See the IDXAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IDEX Biometrics ASA develops and manufactures fingerprint biometric cards for access control, digital identity, and payment. Its products use fingerprint biometrics for user authentication and are designed for physical and digital access applications. The company serves banks, enterprises, and public sector organizations through direct sales and channel partners.
26GF Score
Get the complete analysis for IDXAF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IDXAF has been successfully added to your 
